©The Author(s) 2017.
World J Gastroenterol. Feb 21, 2017; 23(7): 1319-1324
Published online Feb 21, 2017. doi: 10.3748/wjg.v23.i7.1319
Published online Feb 21, 2017. doi: 10.3748/wjg.v23.i7.1319
Table 1 Summary of the treatment and results in a collagenous colitis patient
| Treatment | Result of the treatment |
| Loperamide 2-4 mg per day | Little effect |
| Cholestyramine, 4 g, three times per day | No effect |
| Mesalazine 800 mg twice per day for 4 mo | No effect |
| Budesonide capsules 3 mg 1-3 times per day | Good but declining effect after 2 yr of treatment |
| Azathioprine | Side effects (liver toxicity) |
| Doxycycline, 100 mg per day for 10 d, given twice | Good but temporary effect |
| First FMT, November 2014 | General improvement for 2 wk |
| 200 mL filtrate infused as an enema in the rectum for five consecutive mornings | Not fulfilling the criteria for remission[21] |
| Second FMT, March 2015 | General improvement for 4 wk |
| 300 mL filtrate instilled in cecum | Not fulfilling the criteria for remission |
| Third FMT, May 2015 | Remission with normalized stools and normal BMI achieved for 11 mo |
| 300 mL filtrate instilled in cecum |
- Citation: Günaltay S, Rademacher L, Hultgren Hörnquist E, Bohr J. Clinical and immunologic effects of faecal microbiota transplantation in a patient with collagenous colitis. World J Gastroenterol 2017; 23(7): 1319-1324
- URL: https://www.wjgnet.com/1007-9327/full/v23/i7/1319.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i7.1319